Caxton Associates (UK)’s Arvinas ARVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$684K Sell
82,313
-177,703
-68% -$1.66M 0.01% 482
2026
Q1
$2.76M Sell
260,016
-194,501
-43% -$2.41M 0.06% 144
2025
Q4
$5.39M Sell
454,517
-150,268
-25% -$1.64M 0.11% 58
2025
Q3
$5.15M Buy
604,785
+306,723
+103% +$2.33M 0.12% 66
2025
Q2
$2.19M Buy
+298,062
New +$2.2M 0.06% 173

Other funds holding ARVN

Caxton Associates (UK)'s ARVN Position: Q2 2026 in Review

Caxton Associates (UK) reduced its Arvinas (ARVN) stake by 68% in Q2 2026, selling an estimated $1.66M and leaving 82,313 shares worth $684K. The position accounts for 0.01% of the portfolio, ranked #482.

Caxton Associates (UK) first reported a position in ARVN in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.39M in Q4 2025. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Caxton Associates (UK) held 82,313 shares of Arvinas worth $684K as of Q2 2026.
  • Caxton Associates (UK) sold 177,703 Arvinas shares in Q2 2026, an estimated $1.66M.
  • Arvinas made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #482 holding.
  • Caxton Associates (UK) first reported a position in Arvinas in Q2 2025 and has held it in 5 quarters since.
  • Caxton Associates (UK)'s Arvinas position peaked at $5.39M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.